&#226;€‹Biopharmaceutical company.
Issues related to the FDA STATES Act (S. 3032), and Health and Human Services pertaining to CBD policies. Appropriations issues related to the FDA CBD products, HHS pertaining to CBD policy. Issues related to the FDA and the STATES Act (S. 3032), HHS pertaining to CBD policy.
HCR - Health Issues BUD - Budget/Appropriations MED - Medical/Disease Research/Clinical Labs
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
MATTHEW LEFFINGWELL JOHN MICHAEL GONZALEZ TIMOTHY A MOLINO EMILY KIRLIN MATTHEW LEFFINGWELL JOHN MICHAEL GONZALEZ TIMOTHY A MOLINO EMILY KIRLIN MATTHEW LEFFINGWELL JOHN MICHAEL GONZALEZ TIMOTHY A MOLINO EMILY KIRLIN